GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (LTS:0I3I) » Definitions » Cyclically Adjusted PS Ratio

The Cooper (LTS:0I3I) Cyclically Adjusted PS Ratio : 6.12 (As of Jun. 06, 2024)


View and export this data going back to 2018. Start your Free Trial

What is The Cooper Cyclically Adjusted PS Ratio?

As of today (2024-06-06), The Cooper's current share price is $94.67. The Cooper's Cyclically Adjusted Revenue per Share for the quarter that ended in Apr. 2024 was $15.47. The Cooper's Cyclically Adjusted PS Ratio for today is 6.12.

The historical rank and industry rank for The Cooper's Cyclically Adjusted PS Ratio or its related term are showing as below:

LTS:0I3I' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.23   Med: 6.47   Max: 9.78
Current: 6.09

During the past years, The Cooper's highest Cyclically Adjusted PS Ratio was 9.78. The lowest was 4.23. And the median was 6.47.

LTS:0I3I's Cyclically Adjusted PS Ratio is ranked worse than
75.89% of 477 companies
in the Medical Devices & Instruments industry
Industry Median: 2.15 vs LTS:0I3I: 6.09

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

The Cooper's adjusted revenue per share data for the three months ended in Apr. 2024 was $4.701. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $15.47 for the trailing ten years ended in Apr. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


The Cooper Cyclically Adjusted PS Ratio Historical Data

The historical data trend for The Cooper's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Cyclically Adjusted PS Ratio Chart

The Cooper Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.25 7.49 8.71 5.01 5.25

The Cooper Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.69 6.72 5.25 6.18 5.76

Competitive Comparison of The Cooper's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, The Cooper's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where The Cooper's Cyclically Adjusted PS Ratio falls into.



The Cooper Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

The Cooper's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=94.67/15.47
=6.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper's Cyclically Adjusted Revenue per Share for the quarter that ended in Apr. 2024 is calculated as:

For example, The Cooper's adjusted Revenue per Share data for the three months ended in Apr. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Apr. 2024 (Change)*Current CPI (Apr. 2024)
=4.701/131.7762*131.7762
=4.701

Current CPI (Apr. 2024) = 131.7762.

The Cooper Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201407 2.210 100.520 2.897
201410 2.381 100.176 3.132
201501 2.267 98.604 3.030
201504 2.210 99.824 2.917
201507 2.344 100.691 3.068
201510 2.309 100.346 3.032
201601 2.303 99.957 3.036
201604 2.473 100.947 3.228
201607 2.626 101.524 3.409
201610 2.630 101.988 3.398
201701 2.526 102.456 3.249
201704 2.638 103.167 3.370
201707 2.802 103.278 3.575
201710 2.813 104.070 3.562
201801 3.016 104.578 3.800
201804 3.182 105.708 3.967
201807 3.320 106.324 4.115
201810 3.258 106.695 4.024
201901 3.147 106.200 3.905
201904 3.272 107.818 3.999
201907 3.390 108.250 4.127
201910 3.458 108.577 4.197
202001 3.251 108.841 3.936
202004 2.646 108.173 3.223
202007 2.920 109.318 3.520
202010 3.435 109.861 4.120
202101 3.423 110.364 4.087
202104 3.619 112.673 4.233
202107 3.832 115.183 4.384
202110 3.788 116.696 4.278
202201 3.944 118.619 4.381
202204 4.174 121.978 4.509
202207 4.251 125.002 4.481
202210 4.266 125.734 4.471
202301 4.321 126.223 4.511
202304 4.405 127.992 4.535
202307 4.660 128.974 4.761
202310 4.654 129.810 4.725
202401 4.660 130.124 4.719
202404 4.701 131.776 4.701

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


The Cooper  (LTS:0I3I) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


The Cooper Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of The Cooper's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper (LTS:0I3I) Business Description

Traded in Other Exchanges
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (LTS:0I3I) Headlines

No Headlines